Patents by Inventor Fedor Svinartchouk

Fedor Svinartchouk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11099193
    Abstract: The invention relates to a method for prognosing, diagnosing, determining the risk, and monitoring the evolution of a muscular dystrophy. It also relates to a method for evaluating the efficacy of a treatment of a muscular dystrophy in a subject in need thereof.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: August 24, 2021
    Assignee: GENETHON
    Inventors: Jeremy Rouillon, Fedor Svinartchouk, Jerome Poupiot, Isabelle Richard
  • Patent number: 9933438
    Abstract: A method for the diagnosis, prognosis and therapeutic monitoring of muscular dystrophy, by detecting titin or one or more fragments of titin in a bodily fluid is provided.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: April 3, 2018
    Assignee: GENETHON
    Inventors: Jérémy Rouillon, Fedor Svinartchouk
  • Patent number: 9546112
    Abstract: Methods for increasing the efficiency of target tissue penetration of an adeno-associated virus (AAV) vector in a patient are provided. In some aspects, the methods involve inhibiting the interaction of the serum protein galectin 3 binding protein (G3BP) with AAV vector. Further provided are methods for reducing tissue distribution of a virus or for neutralizing a virus harbored by an organ destined for transplant, or newly transplanted, by administering a composition comprising G3BP.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: January 17, 2017
    Assignees: ASSOCIATION INSTITUT DE MYOLOGIE, GÉNÉTHON, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6), INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
    Inventors: Thomas Voit, Luis Garcia, Jérôme Denard, Fedor Svinartchouk
  • Publication number: 20160334417
    Abstract: The invention relates to a method for prognosing, diagnosing, determining the risk, and monitoring the evolution of a muscular dystrophy. It also relates to a method for evaluating the efficacy of a treatment of a muscular dystrophy in a subject in need thereof.
    Type: Application
    Filed: January 9, 2015
    Publication date: November 17, 2016
    Inventors: JEREMY ROUILLON, FEDOR SVINARTCHOUK, JEROME POUPIOT, ISABELLE RICHARD
  • Publication number: 20150241452
    Abstract: The invention relates to a method for the diagnosis, prognosis and therapeutic monitoring of muscular dystrophy, by detecting titin or one or more fragments of titin in a bodily fluid of a patient.
    Type: Application
    Filed: September 26, 2013
    Publication date: August 27, 2015
    Applicant: GENETHON
    Inventors: Jérémy Rouillon, Fedor Svinartchouk
  • Publication number: 20130189225
    Abstract: Methods for increasing the efficiency of target tissue penetration of an adeno-associated virus (AAV) vector in a patient are provided. In some aspects, the methods involve inhibiting the interaction of the serum protein galectin 3 binding protein (G3BP) with AAV vector. Further provided are methods for reducing tissue distribution of a virus or for neutralizing a virus harbored by an organ destined for transplant, or newly transplanted, by administering a composition comprising G3BP.
    Type: Application
    Filed: March 22, 2011
    Publication date: July 25, 2013
    Applicants: ASSOCIATION INSTITUT DE MYOLOGIE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, GENETHON
    Inventors: Thomas Voit, Luis Garcia, Jérôme Denard, Fedor Svinartchouk